Alseroxylon

Alseroxylon
Reserpine.svg
Reserpine, the major component of alseroxylon
Clinical data
ATC code
Identifiers
CAS Number
DrugBank
ChemSpider
  • None
UNII
ChEMBL
Chemical and physical data
FormulaVaries
 ☒N☑Y (what is this?)  (verify)

Alseroxylon (Rautensin, Rauwiloid) is a norepinephrine reuptake inhibitor that has been investigated in the treatment of hypertension[1] and angina pectoris and as a sedative in psychoses.[2] It was at one time approved for use in the United States, but has since been discontinued.[3]

Alseroxylon is a purified fat-soluble extract of the root of Rauvolfia serpentina, containing reserpine and other nonadrenolytic amorphous alkaloids.[2]

References

  1. ^ Green, R. S.; Davolos, D. (1956). "A long-term study of the effect of crude Rauwolfia serpentina and of its alseroxylon fraction in patients with hypertension". The American Journal of Medicine. 20 (5): 760–773. doi:10.1016/0002-9343(56)90158-9. PMID 13313574.
  2. ^ a b DrugBank DB00386
  3. ^ Approved Drug Products with Therapeutic Equivalence Evaluations. FDA Orange Book (33rd ed.). 2013.

This page was last updated at 2019-11-09 18:16 UTC. Update now. View original page.

All our content comes from Wikipedia and under the Creative Commons Attribution-ShareAlike License.


Top

If mathematical, chemical, physical and other formulas are not displayed correctly on this page, please useFirefox or Safari